Author

Cecilio Santander

GASTROESOPHAGEAL REFLUX DISEASE AFTER PERORAL ENDOSCOPIC MYOTOMY
GASTROESOPHAGEAL REFLUX DISEASE AFTER PERORAL ENDOSCOPIC MYOTOMY

Cecilio Santander  et al.

PROFILING OF HUMAN CIRCULATING DENDRITIC CELLS AND MONOCYTES SUBSETS DISCRIMINATES TYPE AND MUCOSAL STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PROFILING OF HUMAN CIRCULATING DENDRITIC CELLS AND MONOCYTES SUBSETS DISCRIMINATES TYPE AND MUCOSAL STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Cecilio Santander  et al.

EFFECTS OF ANTI-TNF-ALPHA AND ANTI-ALPHA4BETA7 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE
EFFECTS OF ANTI-TNF-ALPHA AND ANTI-ALPHA4BETA7 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE

Cecilio Santander  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWINGTHE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Cecilio Santander  et al.

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL
BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Cecilio Santander  et al.

EFICACY AND SAFETY OF ENDOSCOPIC MUCOSAL RESECTION FOR DIFFICULT COLORECTAL LESIONS
EFICACY AND SAFETY OF ENDOSCOPIC MUCOSAL RESECTION FOR DIFFICULT COLORECTAL LESIONS

Cecilio Santander  et al.

TWO STEP ENDOSCOPIC MUCOSAL RESECTION AND FULL-THICKNESS RESECTION FOR ENDOSCOPIC TREATMENT OF A LARGE ADENOMATOUS RECURRENCE
TWO STEP ENDOSCOPIC MUCOSAL RESECTION AND FULL-THICKNESS RESECTION FOR ENDOSCOPIC TREATMENT OF A LARGE ADENOMATOUS RECURRENCE

Cecilio Santander  et al.

SUSPECTED MALIGNANT DEGENERATION IN A ZENKER’S DIVERTICULUM: SHOULD WE BIOPSY IT?
SUSPECTED MALIGNANT DEGENERATION IN A ZENKER’S DIVERTICULUM: SHOULD WE BIOPSY IT?

Cecilio Santander  et al.

FIBROTIC FEATURES IN THE EOSINOPHILIC ESOPHAGITIS ENDOSCOPIC REFERENCE SCORE IN THE DIAGNOSIS AND RESPONSE TO PROTON-PUMP INHIBITOR THERAPY
FIBROTIC FEATURES IN THE EOSINOPHILIC ESOPHAGITIS ENDOSCOPIC REFERENCE SCORE IN THE DIAGNOSIS AND RESPONSE TO PROTON-PUMP INHIBITOR THERAPY

Cecilio Santander  et al.

IDENTIFICATION OF CONSTITUTIVE MODIFICATIONS IN PLASMA CELLS AND B LYMPHOCYTES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
IDENTIFICATION OF CONSTITUTIVE MODIFICATIONS IN PLASMA CELLS AND B LYMPHOCYTES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Cecilio Santander  et al.

EFFICACY OF PROTON-PUMP INHIBITOR THERAPY FOR EOSINOPHILIC OESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF PROTON-PUMP INHIBITOR THERAPY FOR EOSINOPHILIC OESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Cecilio Santander  et al.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults
Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults

Cecilio Santander  et al.

PROTON PUMP INHIBITOR THERAPY REVERSES FIBROTIC ENDOSCOPIC FEATURES IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOE CONNECT REGISTRY
PROTON PUMP INHIBITOR THERAPY REVERSES FIBROTIC ENDOSCOPIC FEATURES IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOE CONNECT REGISTRY

Cecilio Santander  et al.

DIAGNOSTIC DELAY REDUCES AND DIAGNOSTIC PRECISION INCREASES ALONG TIME FOR EOSINOPHILIC ESOPHAGITIS: AN ANALYSIS FROM THE EOE CONNECT REGISTRY ON THE IMPACT ON CLINICAL PRACTICE GUIDELINES TO IMPROVE DISEASE AWARENESS IN EUROPE
DIAGNOSTIC DELAY REDUCES AND DIAGNOSTIC PRECISION INCREASES ALONG TIME FOR EOSINOPHILIC ESOPHAGITIS: AN ANALYSIS FROM THE EOE CONNECT REGISTRY ON THE IMPACT ON CLINICAL PRACTICE GUIDELINES TO IMPROVE DISEASE AWARENESS IN EUROPE

Cecilio Santander  et al.

SPORADIC VERSUS FAMILIAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS: A COMPARATIVE ANALYSIS OF THE EOE CONNECT REGISTRY ON DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND EARLY-LIFE EXPOSURES
SPORADIC VERSUS FAMILIAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS: A COMPARATIVE ANALYSIS OF THE EOE CONNECT REGISTRY ON DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND EARLY-LIFE EXPOSURES

Cecilio Santander  et al.

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Cecilio Santander  et al.

EFFICACY OF FLUTICASONE AND BUDESONIDE FORMULATIONS TO INDUCE AND MAINTAIN REMISSION OF EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF FLUTICASONE AND BUDESONIDE FORMULATIONS TO INDUCE AND MAINTAIN REMISSION OF EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Cecilio Santander  et al.

Item 1 - 17 / 17
1